Your email has been successfully added to our mailing list.

×
0.00987876066457128 0.00987876066457128 0.00987876066457128 0.00987876066457128 -0.01930848675348 -0.0211046250561293 -0.0134710372698697 -0.0134710372698697
Stock impact report

Nightstar Expands Pipeline with Novel Gene Therapy for the Treatment of Stargardt Disease

NIGHTSTAR THERAPEUTICS PLC AMERICAN DEPOSITARY SHA (NITE) 
Last nightstar therapeutics plc american depositary sha earnings: 11/13 01:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.nightstartx.com/investor-relations
Company Research Source: GlobeNewswire
Fourth Gene Therapy Program Targets the Most Common Inherited Juvenile Macular Dystrophy LEXINGTON, Mass. and LONDON, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Nightstar Therapeutics (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced an expansion of its pipeline with an exclusive global license for a gene therapy program for the treatment of Stargardt disease from Oxford University Innovation. The gene therapy program utilizes a novel technology developed by the University of Oxford. Preclinical proof-of-concept studies in the Abca4-/- murine model of Stargardt disease have demonstrated the expression, localization and function of the ABCA4 protein. Stargardt disease is the most common form of inherited juvenile macular dystrophy with a prevalence of one in 10,000. This autosomal recessive disease is linked to mutations in the ABCA4 gene that are inherited from both parents of an affected individual. The progres Show less Read more
Impact Snapshot
Event Time:
NITE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NITE alerts
Opt-in for
NITE alerts

from News Quantified
Opt-in for
NITE alerts

from News Quantified